Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope, Temperature intolerance, Vision blurred, Vomiting, Weight decreased
Clinical narrative: small fiber neuropathy/numbness/tingling in extremities, skin discoloration,sensitivity to hot and; chronic pain syndrome,bilateral leg; chronic fatigue syndrome/joint pain; POTS-like symptoms autonomic dysfunctions, dysautonomia/ weakness,fatigue,dizziness, syncope, nausea, weigth loss,vomiting, blurred vision,diarrhea,constipation, night sweats,hot flashes,headaches,vasovagal episodes, belching; serious autoimmune, autonomic, and neurological dysfunctions,Abdominal pain,Bloating/ dehydrataion; serious autoimmune, autonomic, and neurological dysfunctions; as well as a constellation of adverse symptoms, complications, injuries, and other adverse events; dehydration; Information has been received from a lawyer regarding a case in litigation, concerning a female patient (pt) of unknown age. The pt's medical history, concurrent conditions, and concomitant medications were not provided. On an unspecified date (when she was 13-years old), the pt was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) intramuscular injection as prevention of cervical cancer (dose, route of administration, anatomical location, lot number, and expiration date were not provided. On an unknown date following vaccination, the patient inexplicably began to experienced headaches, bilateral leg pain, weakness, fatigue, dizziness, syncope, vasovagal episodes, unilateral lower extremity edema and swelling, joint pain, blurred vision, hot flashes, night sweats, sensitivity to hot and cold, skin discoloration, numbness/tingling in extremities, gastrointestinal symptoms, including nausea, bloating, vomiting, abdominal pain, blenching, diarrhea, also she suffered dehydration and weight loss. Based on the mentioned symptoms she was diagnosed with various medical conditions, included but not limited to chronic pain syndrome, chronic fatigue syndrome, dysautonomia, small fiber neuropathy and as well as a constellation of adverse symptoms, complications, injuries, and other adverse events. She stated that the first time she discovered that her injuries could have been caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) was in an unspecified date in summer 2022. As a result of her post-vaccine symptoms, the pt has been unable to engage in activities that a young person her age would normally enjoy. As a result of her debilitating symptoms, she required special academic accommodations, also has been unable to participate in sports she used to enjoy prior to receiving the Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) vaccine.Moreover, as a result of company's alleged wrongful acts and omissions and its negligent and fraudulent testing, labeling, manufacturing, marketing and promotion of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the pt has suffered and would continue to suffer severe and permanent physical injuries, and associated symptomology and has suffered severe and permanent emotional injuries, including pain and suffering. She also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL). Additionally, as a direct and proximate result of her vaccine-induced injuries the pt has suffered and would continue to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity and would continue to incur. The patient had not recovered from the adverse events, and it was considered the events was related to Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL).  The reporter considered all the aforementioned events to be a disabling events.